Anti-Human VEGFA Recombinant Antibody(Ranibizumab)
-
产品编号
YR1040
-
别名
科研级 Ranibizumab ( 雷珠单抗 ), Anti-VEGFA Recombinant Antibody, Research Grade Ranibizumab
-
规格
- 1mg
- 5mg
| Catalog Number | YR1040 |
| Alias | 科研级 Ranibizumab ( 雷珠单抗 ), Anti-VEGFA Recombinant Antibody, Research Grade Ranibizumab |
| Size | 1mg, 5mg |
| Molecular Name | Ranibizumab |
| CAS Number | 347396-82-1 |
| Molecular Weight | 48 kDa |
| Target | VEGFA[Homo sapiens] |
| Antibody Isotype | Fab-G1 Kappa |
| Clonity | Monoclonal |
| Concentration | 1mg/ml |
| Purity | >95% as determined by SDS-PAGE |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Formulation | PBS, pH7.5 |
| Shipping Condition | Shipped on ice packs. |
| Background | Ranibizumab (trade name Lucentis among others) is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as bevacizumab. It is an anti-angiogenic that has been approved to treat the "wet" type of age-related macular degeneration (AMD, also ARMD), diabetic retinopathy, and macular edema due to branch retinal vein occlusion or central retinal vein occlusion. |
| Remarks | This product is for research use only. |
0